Park Avenue Securities LLC Sells 49 Shares of Mettler-Toledo International, Inc. $MTD

Park Avenue Securities LLC lowered its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 16.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 248 shares of the medical instruments supplier’s stock after selling 49 shares during the quarter. Park Avenue Securities LLC’s holdings in Mettler-Toledo International were worth $291,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the stock. CX Institutional boosted its position in Mettler-Toledo International by 18.2% during the second quarter. CX Institutional now owns 175 shares of the medical instruments supplier’s stock worth $206,000 after purchasing an additional 27 shares during the period. Canoe Financial LP boosted its position in Mettler-Toledo International by 11.9% during the second quarter. Canoe Financial LP now owns 58,224 shares of the medical instruments supplier’s stock worth $68,397,000 after purchasing an additional 6,206 shares during the period. Carderock Capital Management Inc. bought a new stake in Mettler-Toledo International during the second quarter worth approximately $206,000. Wealth Enhancement Advisory Services LLC boosted its position in Mettler-Toledo International by 13.1% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 2,490 shares of the medical instruments supplier’s stock worth $3,011,000 after purchasing an additional 288 shares during the period. Finally, Swedbank AB boosted its position in Mettler-Toledo International by 2.3% during the second quarter. Swedbank AB now owns 19,562 shares of the medical instruments supplier’s stock worth $22,980,000 after purchasing an additional 442 shares during the period. Institutional investors own 95.07% of the company’s stock.

Insider Buying and Selling at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total value of $397,500.00. Following the transaction, the chief financial officer owned 5,095 shares in the company, valued at $6,750,875. This trade represents a 5.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of the firm’s stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the transaction, the director owned 283 shares in the company, valued at approximately $368,154.70. This represents a 78.96% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,827 shares of company stock worth $2,371,208 over the last three months. Company insiders own 0.77% of the company’s stock.

Mettler-Toledo International Trading Up 3.1%

Shares of NYSE MTD opened at $1,228.83 on Wednesday. The business has a fifty day simple moving average of $1,269.82 and a 200 day simple moving average of $1,184.67. The firm has a market capitalization of $25.31 billion, a price-to-earnings ratio of 31.12, a PEG ratio of 3.57 and a beta of 1.37. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,521.01.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. The business had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.Mettler-Toledo International’s revenue was up 3.9% on a year-over-year basis. During the same period in the prior year, the company posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on MTD shares. Citigroup upped their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Thursday, August 21st. Evercore ISI cut their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating for the company in a report on Monday, August 4th. Robert W. Baird upped their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Barclays started coverage on Mettler-Toledo International in a report on Tuesday, June 24th. They set an “overweight” rating and a $1,325.00 price target for the company. Finally, Bank of America upped their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a report on Monday, September 22nd. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $1,325.56.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.